Topics

Middle East Respiratory Syndrome MERS Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $1700

02:40 EST 15 Feb 2020 | BioPortfolio Reports

Middle East Respiratory Syndrome MERS Pipeline Review, H2 2019


Summary


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respiratory Syndrome MERS Pipeline Review, H2 2019, provides an overview of the Middle East Respiratory Syndrome MERS Infectious Disease pipeline landscape.


Middle East respiratory syndrome MERS is a viral respiratory disease caused by a coronavirus MERSCoV. Symptoms include fever, cough and shortness of breath. Other symptoms include nausea, vomiting and diarrhea. Pneumonia is common, and sometimes it cause injury to organs, such as the kidneys. Treatment is aimed at relieving symptoms joint pain and fever with fluids and medications.


Report Highlights


Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Middle East Respiratory Syndrome MERS Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Middle East Respiratory Syndrome MERS Infectious Disease, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.


The Middle East Respiratory Syndrome MERS Infectious Disease pipeline guide also reviews of key players involved in therapeutic development for Middle East Respiratory Syndrome MERS and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 4, 7 and 9 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 5 molecules, respectively.


Middle East Respiratory Syndrome MERS Infectious Disease pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The pipeline guide provides a snapshot of the global therapeutic landscape of Middle East Respiratory Syndrome MERS Infectious Disease.

The pipeline guide reviews pipeline therapeutics for Middle East Respiratory Syndrome MERS Infectious Disease by companies and universities/research institutes based on information derived from company and industryspecific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, RD brief, MoA other developmental activities.

The pipeline guide reviews key companies involved in Middle East Respiratory Syndrome MERS Infectious Disease therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Middle East Respiratory Syndrome MERS Infectious Disease therapeutics based on mechanism of action MoA, drug target, route of administration RoA and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Middle East Respiratory Syndrome MERS Infectious Disease


Reasons to buy


Procure strategically important competitor information, analysis, and insights to formulate effective RD strategies.

Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Middle East Respiratory Syndrome MERS Infectious Disease.

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Middle East Respiratory Syndrome MERS Infectious Disease pipeline depth and focus of Indication therapeutics.

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the knowhow what drove them from pipeline.

Original Article: Middle East Respiratory Syndrome MERS Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $1700

NEXT ARTICLE

More From BioPortfolio on "Middle East Respiratory Syndrome MERS Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $1700"

Quick Search

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...